Recombinant Hormone Market Share

Statistics for the 2023 & 2024 Recombinant Hormone market share, created by Mordor Intelligence™ Industry Reports. Recombinant Hormone share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Recombinant Hormone Industry

The recombinant hormone market is consolidated and consists of a few major players. In terms of market share, a few of the major players are currently dominating the market. Collaborations and mergers over the next coming years to share technology and increasing investments for innovation in the field are expected to be observed. Some of the major market players include Eli Lilly and Company, Ferring Pharmaceuticals, Hoffmann La Roche Ltd (Genentech, Inc), Merck & Co Inc, Pfizer Inc, Novo Nordisk A/S, Novartis AG, Ipsen Pharma, LG Life Sciences and Teva Pharmaceutical Industries.

Recombinant Hormone Market Leaders

  1. Eli Lilly and Company

  2. Ferring Pharmaceuticals

  3. F.Hoffmann-La Roche Ltd (Genentech, Inc)

  4. Merck & Co Inc (Merck KGaA)

  5. Pfizer Inc

*Disclaimer: Major Players sorted in no particular order

Recombinant Hormone Market.png

Recombinant Hormone Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)